ENLV CIK: 1596812

Enlivex Ltd.

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.05
FY23:
0.03
FY24:
0.03
FY25:
1.74
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.02
FY23:
0.00
FY24:
0.00
FY25:
0.58
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.07
FY23:
0.04
FY24:
0.03
FY25:
2.33

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.01
FY23:
0.01
FY24:
0.00
FY25:
0.01
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.00
FY23:
0.00
FY24:
0.00
FY25:
0.38
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.06
FY23:
0.03
FY24:
0.02
FY25:
1.93
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.07
FY23:
0.04
FY24:
0.03
FY25:
2.33

All amounts in billions USD Data source:SEC EDGAR